Cover Image
市場調查報告書

核子醫學攝影診斷 (PET、SPECT設備) 的南美市場 - 分析與預測

MediPoint: Nuclear Imaging - South America Analysis and Market Forecasts

出版商 GlobalData 商品編碼 331273
出版日期 內容資訊 英文 239 Pages
訂單完成後即時交付
價格
Back to Top
核子醫學攝影診斷 (PET、SPECT設備) 的南美市場 - 分析與預測 MediPoint: Nuclear Imaging - South America Analysis and Market Forecasts
出版日期: 2014年12月31日 內容資訊: 英文 239 Pages
簡介

本報告提供南美的核子醫學攝影診斷(PET、SPECT設備等)相關的市場相關分析,疾病概要和市場結構,目前未滿足需求,主要的推動及阻礙市場要素,今後的市場機會,現在臨床實驗中的主要產品,主要國家的市場趨勢(過去3年的實際成果值和今後7年的預測值),各類型產品的詳細趨勢,主要企業簡介等調查

第1章 目錄

第2章 簡介

第3章 產業概要

  • 放射性影像技術
    • 正子斷層掃描 (PET)
    • 單光子發射電腦斷層掃描 (SPECT)
    • 平面顯像
    • 混合型影像診斷法
  • 核子醫學攝影技術臨床現場的用途
    • 癌症
    • 心臟病
    • 神經症
    • 感染疾病及發炎
  • 核子醫學攝影診斷技術的優點、缺點
  • 市場進入
    • 產品的生命週期
    • 購買意願決策
    • 設備租賃
    • PET/核磁共振攝影的PET/CT替換
  • 償付
  • 治療趨勢
  • 法規上的課題/回收
  • M&A及主要的聯盟
  • 經濟影響

第4章 未滿足需求

  • 概要
  • 對於新技術的醫療費償付的改善
  • 缺乏有強制力的臨床指南
  • 患者的舒適性及方便
  • 放射線暴露量的減少
  • 掃描儀的性能改善
  • 影像處理軟體的改善
  • 混合型影像處理的人為風險增加
  • 對新的放射性示蹤物的需求
  • 對設計流程的臨床性輸入的改善

第5章 市場機會分析

  • 更便宜簡單的核子醫學影像設備
  • 在開發中國家的SPECT/CT
  • 遠距放射線醫學服務的需求增加

第6章 市場推動因素及障礙

  • 推動因素:老年人及患病人數的增加
  • 推動因素:醫生的認識度提高
  • 推動因素:防禦性醫療
  • 推動因素:患者的認識
  • 推動因素:任意詢問
  • 推動因素:新的顯影劑
  • 推動因素:癌症診斷檢驗的需求擴大
  • 推動因素:搭配診斷檢驗
  • 障礙:競爭產品的有效性研究
  • 障礙:醫療費償付法案
  • 障礙:發展中國家市場上的核子醫學攝影診斷的需求擴大
  • 障礙:減少不必要的影像診斷之保險公司的遊說
  • 障礙:EMR的保險調查的對象者的擴大
  • 障礙:有效性標準的使用增加
  • 障礙:減少不必要的次序的診療指南
  • 障礙:影像設備的認證
  • 障礙:核醫學技術的不足
  • 障礙:設備、試劑的高成本性
  • 障礙:放射性醫藥品的成本、供給方面的困難性
  • 障礙:醫院的整合

第7章 競爭評估

  • 概要
  • PET專用設備
    • 概要
    • 產品簡介
    • SWOT分析
  • PET/CT設備
  • PET/核磁共振造影系統
  • SPECT專用設備
  • SPECT/CT設備
  • PET/超音波及SPECT/超音波設備

第8章 開發中產品的評估

  • 概要
  • 發展階段的開發中產品
  • 產品簡介(共11種產品)

第9章 關注臨床檢驗

  • 概要
  • 臨床實驗簡介

第10章 現在及未來的主要企業

  • 概要
  • 企業策略趨勢
  • 企業簡介
    • DDD-Diagnostic
    • Digirad
    • GE Healthcare
    • GVI Medical Devices
    • Mediso Medical Imaging Systems
    • NeuroLogica
    • Neusoft Medical Systems
    • NuCare Medical Systems
    • Oncovision
    • Philips Healthcare
    • 島津製作所
    • Siemens Healthcare
    • SurgicEye
    • 東芝 Medical Systems
    • 其他的企業

第11章 市場展望

  • 企業市場佔有率分析
  • 各市場部門構成比
    • SPECT及SPECT/CT
    • PET、PET/CT及PET/核磁共振攝影
  • 各地區
    • 巴西

第12章 附錄

目錄
Product Code: GDME1130CFR

This report examines how new technologies can emerge in the face of economic pressures that may affect the demand for nuclear imaging, and how healthcare reforms are impacting nuclear medicine. The advent of hybrid imaging has enabled PET/CT imaging to undergo explosive growth. However, this has been at the cost of an increased demand on struggling healthcare budgets. PET and SPECT imaging are well established techniques within nuclear imaging, and are the main focus of this report PET imaging uses Positron Emitting radioactive tracers with a short half life, to image metabolically active organs PET combined with CT allows precise anatomical imaging of the body, identifying diseased areas depending upon the tracer used PET/CT is most often used for cancer diagnosis PET/MRI is a new technique that was introduced to reduce patient exposure to radiation PET only systems are now generally considered obsolete, due to the superior imaging quality of PET/CT

The Brazilian (South American) nuclear imaging market was dominated by GE Healthcare and Siemens Healthcare, which each accounted for 40% of the market share in terms of revenue in 2012, The population in Brazil is both rapidly expanding but also experiencing increases in diseases, such as cardiovascular disease, that are associated with an increased adoption of Western lifestyles. Increased access to cardiovascular imaging facilities will also increase access to SPECT-only systems.

Scope

  • An overview of Nuclear Imaging, which includes epidemiology, etiology, symptoms, diagnosis, pathology and treatment guidelines.
  • Annualized South America Nuclear Imaging market revenue and future forecasts from 2011 to 2013, forecast for 7 years to 2020.
  • Investigation of current and future market competition for Nuclear Imaging.
  • Insightful review of the key industry drivers, restraints and challenges as well as predicted impact of key events.
  • Competitor assessment including device approval analysis and device sales forecasts.
  • Marketed and pipeline product profiles covering efficiency, safety, clinical study details, device approvals, product positioning and device sales forecast.
  • Analysis of unmet needs within the market and opportunities for future players.
  • Technology trends evaluation to assess strength of pipeline.
  • An overview of all devices in development including clinical study details, design and material selection considerations, efficacy reports, and device approval timelines.
  • Company profiles including business description, financial overview and SWOT analysis.
  • Coverage of key market players.
  • Strategic assessment of the Nuclear Imaging sector through market impact analysis, future market scenario and company analysis.
  • Direct quotes from Key Opinion Leaders (KOL) as well as doctors

Reasons to buy

  • Understand the trends shaping and driving South America Nuclear Imaging market.
  • Realize device preferences of physicians who have performed the tests already.
  • Access market sizing, forecasts and quantified growth opportunities in South America Nuclear Imaging market through 2018.
  • Quantify candidate patient populations to better design product pricing & launch plans.
  • Drive revenues, formulate effective sales and marketing strategies and gain in-depth understanding of the competitive landscape.
  • Perform benchmarking analysis of growth opportunities against currently marketed products.
  • Assess competitiveness of products in market by understanding the strengths and weaknesses of current competition.
  • Take a comprehensive look at the market's device pipeline and identify promising, paradigm-shifting products.
  • Create an effective counter-strategy to gain a competitive advantage against those currently in the market.
  • Organize your sales and marketing efforts by identifying the market categories and segments that present the best opportunities for growth.
  • What's the next big thing in South America Nuclear Imaging market landscape? Identify, understand and capitalize.

Table of Contents

1. Table of Contents

  • 1.1. List of Tables
  • 1.2. List of Figures

2. Introduction

  • 2.1. Catalyst
  • 2.2. Related Reports

3. Industry Overview

  • 3.1. Nuclear Imaging Techniques
    • 3.1.1. Positron Emission Tomography
    • 3.1.2. Single-Photon Emission Computed Tomography
    • 3.1.3. Planar Scintigraphy
    • 3.1.4. Hybrid Imaging
  • 3.2. Clinical Applications of Nuclear Imaging Technology
    • 3.2.1. Cancer
    • 3.2.2. Cardiology
    • 3.2.3. Neurology
    • 3.2.4. Infection and Inflammation
  • 3.3. Advantages and Disadvantages of Nuclear Imaging Technologies
  • 3.4. Market Access
    • 3.4.1. Product Life Cycle
    • 3.4.2. Purchasing Decisions
    • 3.4.3. Equipment Leasing
    • 3.4.4. Replacement of PET/CT by PET/MRI
  • 3.5. Reimbursement
    • 3.5.1. Overview
    • 3.5.2. Brazil
  • 3.6. Procedure Trends
    • 3.6.1. Brazil
  • 3.7. Regulatory Issues/Recalls
  • 3.8. M&As and Key Partnerships
  • 3.9. Economic Impact
    • 3.9.1. Europe

4. Unmet Needs

  • 4.1. Overview
  • 4.2. Improved Reimbursement for New Techniques
  • 4.3. Lack of Binding Clinical Guidelines
  • 4.4. Patient Comfort and Convenience
  • 4.5. Reducing Radiation Exposure
  • 4.6. Improved Scanner Performance
  • 4.7. Image Processing Software Improvements
  • 4.8. Increased Risk of Artifacts in Hybrid Images
  • 4.9. Demand for New Radiotracers
  • 4.10. Improved Clinical Input into the Design Process

5. Market Opportunity Analysis

  • 5.1. Cheaper, Simpler Nuclear Imaging Devices
  • 5.2. SPECT/CT in Developing Countries
  • 5.3. Increased Demand for Teleradiology Services

6. Market Drivers and Barriers

  • 6.1. Driver: Aging Population and Increasing Disease Prevalence
  • 6.2. Driver: Referring Physician Awareness
  • 6.3. Driver: Defensive medicine
  • 6.4. Driver: Patient Awareness
  • 6.5. Driver: Self-Referral
  • 6.6. Driver: New Imaging Agents
  • 6.7. Driver: Increasing Demand for Cancer Diagnostic Tests
  • 6.8. Driver: Companion Diagnostic Testing
  • 6.9. Barrier: Comparative Effectiveness Research
  • 6.10. Barrier: Reimbursement Legislation
  • 6.11. Barrier: Increasing Demand for Nuclear Imaging in Developing Markets
  • 6.12. Barrier: Insurance Company Lobbying to Reduce Unnecessary Imaging
  • 6.13. Barrier: Greater Payer Scrutiny of EMRs
  • 6.14. Barrier: Increased Use of Appropriateness Criteria
  • 6.15. Barrier: Practice Guidelines to Reduce Unnecessary Procedures
  • 6.16. Barrier: Imaging Facility Accreditation
  • 6.17. Barrier: Loss of Nuclear Medicine Skills
  • 6.18. Barrier: High Cost of Instruments and Reagents
  • 6.19. Barrier: Radiopharmaceutical Cost and Supply Difficulties
  • 6.20. Barrier: Hospital Consolidation

7. Competitive Assessment

  • 7.1. Overview
  • 7.2. Dedicated PET Systems
    • 7.2.1. Overview
    • 7.2.2. Product Profile
    • 7.2.3. SWOT Analysis
  • 7.3. PET/CT Systems
    • 7.3.1. Overview
    • 7.3.2. Product Profiles
    • 7.3.3. SWOT Analysis
  • 7.4. PET/MRI Systems
    • 7.4.1. Overview
    • 7.4.2. Product Profile
    • 7.4.3. SWOT Analysis
  • 7.5. Dedicated SPECT Systems
    • 7.5.1. Overview
    • 7.5.2. Product Profile
    • 7.5.3. SWOT Analysis
  • 7.6. SPECT/CT Systems
    • 7.6.1. Overview
    • 7.6.2. Product Profile
    • 7.6.3. SWOT Analysis
  • 7.7. PET/Ultrasound and SPECT/Ultrasound Systems
    • 7.7.1. Overview
    • 7.7.2. Product Profile
    • 7.7.3. SWOT Analysis

8. Pipeline Assessment

  • 8.1. Overview
  • 8.2. Pipeline by Phases in Development
  • 8.3. Product Profiles
    • 8.3.1. Brain Biosciences CerePET
    • 8.3.2. ECORAD Dual Modality Imager
    • 8.3.3. FMI Technologies ScintiStar PET/CT
    • 8.3.4. IntraMedical Imaging Marginator Beta Camera
    • 8.3.5. INSERT SPECT/MRI
    • 8.3.6. Nucare/Zecotek Photonics New Generation PET Scanning Device
    • 8.3.7. Philips Healthcare PET Alpha Ring Detector
    • 8.3.8. Photo Diagnostic Systems NeuroPET/CT
    • 8.3.9. SynchroPET Breast PET/MRI
    • 8.3.10. SynchroPET Wrist Scanner
    • 8.3.11. SurgicEye SPECT Hybrid

9. Clinical Trials to Watch

  • 9.1. Overview
  • 9.2. Clinical Trial Profiles

10. Current and Future Players

  • 10.1. Overview
  • 10.2. Trends in Corporate Strategy
  • 10.3. Company Profiles
    • 10.3.1. DDD-Diagnostic
    • 10.3.2. Digirad
    • 10.3.3. GE Healthcare
    • 10.3.4. GVI Medical Devices
    • 10.3.5. Mediso Medical Imaging Systems
    • 10.3.6. NeuroLogica
    • 10.3.7. Neusoft Medical Systems
    • 10.3.8. NuCare Medical Systems
    • 10.3.9. Oncovision
    • 10.3.10. Philips Healthcare
    • 10.3.11. Shimadzu
    • 10.3.12. Siemens Healthcare
    • 10.3.13. SurgicEye
    • 10.3.14. Toshiba Medical
    • 10.3.15. Other Companies

11. Market Outlooks

  • 11.1. Company Market Share Analysis
  • 11.2. By Geography
    • 11.2.1. Brazil

12. Appendix

  • 12.1. Abbreviations
  • 12.2. Bibliography
  • 12.3. Methodology
    • 12.3.1. Overview
    • 12.3.2. Coverage
    • 12.3.3. Secondary Research
  • 12.4. Physicians and Specialists Included in This Study
  • 12.5. Primary Research
    • 12.5.1. Primary Research - Key Opinion Leader Interviews
    • 12.5.2. Expert Panel Validation
    • 12.5.3. Stakeholder Survey
  • 12.6. Forecasting Methodology
  • 12.7. About the Authors
    • 12.7.1. Andrew Thompson, PhD, Senior Analyst
    • 12.7.2. Priya Radhakrishnan, MBA, Director, Medical Devices
    • 12.7.3. Bonnie Bain, PhD, Global Head of Healthcare
  • 12.8. About GlobalData
  • 12.9. Disclaimer

List of Tables

  • Table 1: Applications of Nuclear Imaging
  • Table 2: FDG-PET Diagnostic Accuracy for Specific Cancers
  • Table 3: Potential Clinical Benefits of Hybrid Nuclear Imaging in Cardiology
  • Table 4: Applications of PET Imaging in Non-Cancer Neurology
  • Table 5: Applications of SPECT Imaging in Non-Cancer Neurology
  • Table 6: Characteristics of SPECT, PET, Ultrasound, CT, and MRI
  • Table 7: The Age of Canada's Hospital-Based Medical Technology Inventories, Relative to ECCREI Rules, 2009
  • Table 8: Nuclear Imaging Trends in Brazil, 2012-2020
  • Table 9: Recent Device Recalls in the Nuclear Imaging Market
  • Table 10: Recent Key Events in the Nuclear Imaging Market
  • Table 11: Nuclear Imaging Market Drivers and Barriers
  • Table 12: Duplicate Diagnostic Test Incidence in France, Germany, UK, and US
  • Table 13: Dedicated PET Scanners
  • Table 14: Dedicated PET SWOT Analysis
  • Table 15: PET/CT Scanners
  • Table 16: PET/CT SWOT Analysis
  • Table 17: PET/MRI Systems
  • Table 18: PET/MRI SWOT Analysis
  • Table 19: Dedicated SPECT Systems
  • Table 20: Dedicated SPECT SWOT Analysis
  • Table 21: SPECT/CT Systems
  • Table 22: SPECT/CT SWOT Analysis
  • Table 23: SPECT-Ultrasound Systems
  • Table 24: SPECT/Ultrasound SWOT Analysis
  • Table 25: Nuclear Imaging Pipeline, 2014
  • Table 26: CerePET SWOT Analysis
  • Table 27: ECORAD Dual Modality Imager SWOT Analysis
  • Table 28: ScintiStar PET/CT SWOT Analysis
  • Table 29: Marginator SWOT Analysis
  • Table 30: INSERT SPECT-MRI SWOT Analysis
  • Table 31: Nucare/Zecotek Photonics New Generation PET Scanning Device SWOT Analysis
  • Table 32: PET Alpha Ring Detector
  • Table 33: NeuroPET/CT Scanner SWOT Analysis
  • Table 34: SynchroPET Breast PET/MRI SWOT Analysis
  • Table 35: SynchroPET Wrist Scanner
  • Table 36: SurgicEye SPECT/Ultrasound device SWOT Analysis
  • Table 37: Key Clinical Trials
  • Table 38: Company Profile - DDD-Diagnostic
  • Table 39: DDD-Diagnostic SWOT Analysis
  • Table 40: Company Profile - Digirad
  • Table 41: Digirad SWOT Analysis
  • Table 42: Company Profile - GE Healthcare
  • Table 43: GE Healthcare Product Portfolio
  • Table 44: GE Healthcare SWOT Analysis
  • Table 45: Company Profile - GVI Medical Devices
  • Table 46: GVI Medical Devices SWOT Analysis
  • Table 47: Company Profile - Mediso Medical Imaging Systems
  • Table 48: Mediso Medical Imaging Systems SWOT Analysis
  • Table 49: Company Profile - Neurologica
  • Table 50: Neurologica SWOT Analysis
  • Table 51: Company Profile - Neusoft Medical Systems
  • Table 52: Neusoft Medical Systems SWOT Analysis
  • Table 53: Company Profile - NuCare Medical Systems
  • Table 54: Nucare Medical Systems SWOT Analysis
  • Table 55: Company Profile - Oncovision
  • Table 56: Oncovision SWOT Analysis
  • Table 57: Company Profile - Philips Healthcare
  • Table 58: Philips Healthcare SWOT Analysis
  • Table 59: Company Profile - Shimadzu
  • Table 60: Shimadzu SWOT Analysis
  • Table 61: Company Profile - Siemens Healthcare
  • Table 62: Siemens Healthcare SWOT Analysis
  • Table 63: Company Profile - SurgicEye
  • Table 64: SurgicEye SWOT Analysis
  • Table 65: Company Profile - Toshiba Medical
  • Table 66: Toshiba Medical SWOT Analysis
  • Table 67: Other Companies in the Nuclear Imaging Market, 2014
  • Table 68: South America Sales of PET and SPECT Imaging Systems, 2012-2020
  • Table 69: Brazil Market Value Forecast by Market Sub-segment (2012-2020)
  • Table 70: Primary Research Summary
  • Table 71: Primary Research Participants Affiliation

List of Figures

  • Figure 1: Cyclotron Distribution in 10 Countries
  • Figure 2: Localization of Tumor in Chest Cavity by PET, CT, and PET/CT
  • Figure 3: Mutually Beneficial Effects of PET/MRI Imaging
  • Figure 4: Nuclear Imaging Trends in Brazil, 2012-2020
  • Figure 5: Total Medicare Expenditures for Imaging Services Paid Under the Physician Fee Schedule, 2000-2006
  • Figure 6: Imaging Utilization Rates (Number of Outpatient Visits with MRI/CT per 1,000 Persons), by Year in the US
  • Figure 7: Brazil Company Market Shares for Nuclear Imaging Equipment (2012)
  • Figure 8: South America Sales of PET and SPECT Imaging Systems, 2012-2020
  • Figure 9: Brazil Market Value Forecast by Market Sub segment (2012-2020)
  • Figure 10: Primary Research Summary
  • Figure 11: Primary Research Participants Affiliation
Back to Top